Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Inv. presentation
Quarterly results
Asset acq. complete
Director departure
CC transcript
Asset disposition
Acq. announced
Protagenic Therapeutics, Inc.\new (PTIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/22/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ...
Docs: "CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PROTAGENIC THERAPEUTICS, INC. Protagenic Therapeutics, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware , hereby certifies as follows: 1. That the Board of Directors duly adopted resolutions approving the amendment of the Certificate of Incorporation of this corporation to effect a reverse stock split in the range of 1-for-2 to 1-for-4, with the exact ratio to be set within that range at the discretion of our board of directors without further approval or authorization of our stockholders and with our board of directors able to elect to abandon such proposed amendment and not effect the reverse split authorized by sto...",
"Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split"
11/28/2022 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
09/02/2022 8-K Other Events  Interactive Data
06/29/2022 8-K Quarterly results
10/05/2021 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
10/01/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
08/18/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update"
07/23/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial"
07/02/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "At Market Issuance Sales Agreement, by and between Protagenic Therapeutics, Inc., B. Riley Securities, Inc. and EF Hutton, division of Benchmark Investments, LLC",
"Opinion of Duane Morris LLP"
04/30/2021 8-K Quarterly results
04/21/2021 8-K Quarterly results
04/07/2021 8-K Quarterly results
10/07/2020 8-K Quarterly results
09/03/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
07/21/2020 8-K Quarterly results
07/09/2020 8-K Quarterly results
05/14/2020 8-K Quarterly results
05/08/2020 8-K Quarterly results
03/31/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Letter from Independent Auditors regarding Reasons for the Inability to Timely Issue the Audit Report"
03/02/2020 8-K Quarterly results
01/29/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
12/23/2019 8-K Quarterly results
12/04/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
11/21/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Convertible Note Purchase Agreement",
"Form of Convertible Promissory Note",
"Form of Guaranty"
09/24/2019 8-K Submission of Matters to a Vote of Security Holders
06/14/2019 8-K Other Events
02/19/2019 8-K Quarterly results
07/25/2018 8-K Submission of Matters to a Vote of Security Holders
07/02/2018 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slide deck used to describe the Company to prospective corporate partners used during May and June 2018"
06/13/2018 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Stockholder letter and Annual Report cover page issued on June 13, 2018"
06/01/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Second Amended and Restated Bylaws of Protagenic Therapeutics, Inc"
02/23/2018 8-K Other Events
09/28/2017 8-K Quarterly results
07/28/2017 8-K Form 8-K - Current report:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy